CCM
IRWD icon

Consonance Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Consonance Capital Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-3,936,068
Closed -$52.3M – 26
2016
Q3 		$52.3M Sell
3,936,068
-1,949,324
-33% -$22.8M 5.04% 9
2016
Q2 		$64.4M Sell
5,885,392
-17,910
-0.3% -$175K 9.12% 4
2016
Q1 		$54.1M Buy
+5,903,302
New +$48.7M 8.18% 4

Other funds holding IRWD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Consonance Capital Management's IRWD Position: Q4 2016 in Review

Consonance Capital Management sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2016, closing a stake of 3,936,068 shares — an estimated $52.3M sold.

Consonance Capital Management first reported a position in IRWD in Q1 2016 and held it in 3 quarters. The position peaked at $64.4M in Q2 2016. 163 funds tracked by Wall St. Rank hold IRWD as of Q4 2016.

  • Consonance Capital Management reported no remaining Ironwood Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Consonance Capital Management sold 3,936,068 Ironwood Pharmaceuticals shares in Q4 2016, an estimated $52.3M.
  • Consonance Capital Management first reported a position in Ironwood Pharmaceuticals in Q1 2016 and held it in 3 quarters.
  • Consonance Capital Management's Ironwood Pharmaceuticals position peaked at $64.4M in Q2 2016.
  • 163 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2016.

Based on Consonance Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.